JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMorgan Chase & Co. released FY2025 9-month earnings on October 14 (EST), actual revenue USD 127.09 B, actual EPS USD 1.538

JPMorgan Chase & Co. released FY2024 9 Months Earnings on October 11, 2024 (EST), actual revenue USD 126.64 B, actual EPS USD 1.493

OPTIMI HEALTH CORP

HCW Biologics

GCL Global

Silexion Therapeutics

Micware

BiomX

MicroAlgo

Vida Global

MetaVia

Tradr 2X Long XNDU Daily ETF

JPM-D

JPM-J

JPM-K

JP Morgan has received approval to construct the tallest skyscraper in Canary Wharf, an 869ft tower that will serve as its new UK headquarters, accommodating up to 12,000 staff. The £3bn project will be the third-tallest in London, following an agreement on height restrictions with City Airport. The bank is seeking government support for a tax discount to proceed, which could save millions and contribute £9.9bn to the UK economy over six years. Final designs will be submitted for planning approval by Tower Hamlets local authority.

The telegraph

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

Defiance Daily Target 2X Long JPM ETF

JPMorgan Chase

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

JP Morgan gets green light to build Canary Wharf’s tallest tower

FNCL

JPMorgan Chase & Co. (NYSE:JPM) launched the "American Dream Initiative" to support 10 million small businesses, boosting local economies. The stock rose 1.5% in premarket trading, reflecting positive momentum. The initiative focuses on financing, training, and advocating for policies that aid small business growth and affordable housing. CEO Jamie Dimon aims to make economic opportunities more accessible. Despite the stock's recent strength, it remains in a downtrend, trading below key moving averages. Analysts maintain a Buy rating with a price target of $326.94, as the company prepares to report earnings on April 14, 2026.

benzinga_article

VG Financial

Financial Select Sector SPDR Fund

ISHRS Us Brokers & Sec Exchg

Fidelity MSCI Financials Index

JPMorgan Chase Aims To Transform Local Economies With Targeted Investments

MATV

Mativ Holdings Inc. has priced a $500 million leveraged loan at a significant discount, led by JPMorgan Chase & Co. The loan, aimed at refinancing existing debt, was set at 4.5 percentage points over the benchmark and 95 cents on the dollar, reflecting waning investor demand for risky debt amid market volatility. This year, only two US leveraged loans have been priced at deeper discounts. Mativ faces challenges with a heavy debt load and weak demand in certain industrial sectors.

Bloomberg

Mativ

Mativ Holdings Prices $500 Million Junk Loan at Steep Discount

Immediately after yesterday’s close, Trump announced another delay in the ceasefire deal from today to April 6th. Futs went up after the announcement but have been quickly reversing and now in the red.Unlike the initial 5-day ceasefire window, yesterday’s statement failed to support price actions in equities, oil, or rates.THOUGHTS INTO THE WEEKEND

ZeroHedge

What's The Trade? JPMorgan Traders' Thoughts Ahead Of 'Another Action-Packed Weekend?'

JPMorgan Chase & Co. reduced its stake in Bank of N.T. Butterfield & Son Limited by 8.4% in Q3, now holding 693,287 shares valued at approximately $29.76 million. Other institutional investors, including Millennium Management and Assenagon Asset Management, increased their positions significantly. Analysts have mixed ratings on the stock, with a consensus rating of "Moderate Buy" and a price target of $55.00. The stock opened at $50.77, with a market cap of $2.13 billion and a recent EPS of $1.54, exceeding estimates. A quarterly dividend was also announced.

Market Beat

Bank of NT Butterfield & Son

Bank of N.T. Butterfield & Son Limited (The) $NTB Shares Sold by JPMorgan Chase & Co.

DOCU

JPMorgan Chase & Co. has lowered its price target for Docusign (NASDAQ:DOCU) from $78.00 to $65.00, maintaining a "neutral" rating. This suggests a potential upside of 36.13% from the current price of $47.75. Other analysts have also adjusted their targets, with a consensus rating of "Hold" and an average price target of $67.73. Docusign reported a quarterly EPS of $1.01, exceeding estimates, with revenue up 7.8% year-over-year. Insider trading activity has seen significant share sales by executives recently.

iShares Expanded Tech Software Sector ETF

SPDR S&P Software

Docusign

JPMorgan Chase & Co. Lowers Docusign (NASDAQ:DOCU) Price Target to $65.00

JPMorgan has revised its forecast for Turkey's Consumer Price Index (CPI) by the end of 2026, increasing it to 25% from the previous estimate of 24%. According to Jin10, the adjustment is attributed to rising oil prices, an expanding current account deficit, and potential capital outflows. These factors are expected to exert additional pressure on Turkey's economy, prompting the financial institution to reassess its inflation expectations. The revised forecast reflects concerns over the country's economic stability and the challenges it faces in managing inflationary pressures.

CoinLive

JPMorgan Raises Turkey's 2026 CPI Forecast to 25% Amid Economic Concerns

JPMorgan Chase has acknowledged closing President Trump's bank accounts following the January 6 Capitol attack. In a court filing, the bank's former chief administrative officer stated that certain accounts were closed in February 2021. Trump's lawsuit claims the closure was politically motivated. JPMorgan has denied the allegations, stating the lawsuit lacks merit. Trump's legal team argues that the bank's actions caused significant financial harm and asserts that the case represents a broader issue of conservative customers being debanked.

Thehill

JPMorgan admits to closing Trump's accounts after Jan. 6 Capitol attack

SCHE

J.P. Morgan Markets Limited disclosed its position regarding Spire Healthcare Group plc under Rule 8.5 of the Takeover Code. As of February 18, 2026, J.P. Morgan holds no relevant securities in Spire Healthcare. The firm made a purchase and sale of 1,428 ordinary shares at a price of 2.0130 GBP. No other agreements or arrangements were reported. The disclosure was made on February 19, 2026, by Hetvi Shah.

London Stock Exchange

Southern Cross Healthcare Group PLC

REG - J.P. Morgan Markets Spire Healthcare Grp - Form 8.5 (EPT/NON-RI)-Spire Healthcare Group plc

MNZS

Morgan Stanley & Co. International plc disclosed its dealings in John Wood Group plc's securities as per Rule 8.5 of the Takeover Code. On February 19, 2026, the firm sold 864,389 ordinary shares at prices ranging from £0.2640 to £0.2672 and purchased 922,071 shares at prices between £0.2640 and £0.2676. Additionally, it increased and reduced short positions in cash-settled derivatives. No other agreements or arrangements were reported. The disclosure was made on February 20, 2026, by Claire Gordon.

John Menzies plc

REG - Morgan Stanley & Co. Wood Group (John) PLC - Form 8.5 (EPT/RI) - John Wood Group plc

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ(JPM-K.US)